SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Fredun Pharmaceuticals informs about certificate

03 Jan 2023 Evaluate

In compliance to Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018; Fredun Pharmaceuticals has informed that it enclosed Certificate dated January 02, 2023 received from the SEBI Registered Registrar and Share Transfer Agent (RTA) - Purva Sharegistry (India) for the quarter ended December 31, 2022.

The above information is a part of company’s filings submitted to BSE.

Fredun Pharma Share Price

2590.15 -168.65 (-6.11%)
03-Jul-2026 13:49 View Price Chart
Peers
Company Name CMP
Sun Pharma. Inds. 1903.25
Dr. Reddys Labs. 1376.00
Cipla 1460.80
Zydus Lifesciences 1128.70
Lupin 2466.25
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through: